Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Ueckert

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|July 4, 2020
Performance of longitudinal item response theory models in shortened or partial assessmentsLeticia Arrington, Sebastian Ueckert, Malidi Ahamadi, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 28, 2013
Optimizing disease progression study designs for drug effect discriminationSebastian Ueckert, Stefanie Hennig, Joakim Nyberg, et al.
The AAPS Journal|March 1, 2019
Model-Based Conditional Weighted Residuals Analysis for Structural Model AssessmentMoustafa M A Ibrahim, Sebastian Ueckert, Svetlana Freiberga, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 8, 2014
Evaluation of bias, precision, robustness and runtime for estimation methods in NONMEM 7Åsa M Johansson, Sebastian Ueckert, Elodie L Plan, et al.
Computer Methods and Programs in Biomedicine|May 30, 2012
PopED: an extended, parallelized, nonlinear mixed effects models optimal design toolJoakim Nyberg, Sebastian Ueckert, Eric A Strömberg, et al.
Pharmaceutical Research|March 6, 2014
Improved utilization of ADAS-cog assessment data through item response theory based pharmacometric modelingSebastian Ueckert, Elodie L Plan, Kaori Ito, et al.
Clinical Pharmacology and Therapeutics|July 4, 2024
From Plan to Pivot: How Model-Informed Drug Development Shaped the Dose Strategy of the Zibotentan/Dapagliflozin ZENITH TrialsAnne-Kristina Mercier, Sebastian Ueckert, Mikael Sunnåker, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 5, 2025
Predictors of Ability to Work in Multiple SclerosisGustaf J Wellhagen, Sebastian Ueckert, Elisabet Nielsen, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 19, 2023
Evaluation of the effect of erenumab on migraine-specific questionnaire in patients with chronic and episodic migrainePo-Wei Chen, Mats O Karlsson, Sebastian Ueckert, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 26, 2023
A Markov model of fibrosis development in nonalcoholic fatty liver disease predicts fibrosis progression in clinical cohortsJane Knöchel, Linnéa Bergenholm, Eman Ibrahim, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Pharmacokinetics and Pharmacodynamics|July 4, 2020
Performance of longitudinal item response theory models in shortened or partial assessmentsLeticia Arrington, Sebastian Ueckert, Malidi Ahamadi, et al.
Journal of Pharmacokinetics and Pharmacodynamics|August 28, 2013
Optimizing disease progression study designs for drug effect discriminationSebastian Ueckert, Stefanie Hennig, Joakim Nyberg, et al.
The AAPS Journal|March 1, 2019
Model-Based Conditional Weighted Residuals Analysis for Structural Model AssessmentMoustafa M A Ibrahim, Sebastian Ueckert, Svetlana Freiberga, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 8, 2014
Evaluation of bias, precision, robustness and runtime for estimation methods in NONMEM 7Åsa M Johansson, Sebastian Ueckert, Elodie L Plan, et al.
Computer Methods and Programs in Biomedicine|May 30, 2012
PopED: an extended, parallelized, nonlinear mixed effects models optimal design toolJoakim Nyberg, Sebastian Ueckert, Eric A Strömberg, et al.
Pharmaceutical Research|March 6, 2014
Improved utilization of ADAS-cog assessment data through item response theory based pharmacometric modelingSebastian Ueckert, Elodie L Plan, Kaori Ito, et al.
Clinical Pharmacology and Therapeutics|July 4, 2024
From Plan to Pivot: How Model-Informed Drug Development Shaped the Dose Strategy of the Zibotentan/Dapagliflozin ZENITH TrialsAnne-Kristina Mercier, Sebastian Ueckert, Mikael Sunnåker, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 5, 2025
Predictors of Ability to Work in Multiple SclerosisGustaf J Wellhagen, Sebastian Ueckert, Elisabet Nielsen, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 19, 2023
Evaluation of the effect of erenumab on migraine-specific questionnaire in patients with chronic and episodic migrainePo-Wei Chen, Mats O Karlsson, Sebastian Ueckert, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 26, 2023
A Markov model of fibrosis development in nonalcoholic fatty liver disease predicts fibrosis progression in clinical cohortsJane Knöchel, Linnéa Bergenholm, Eman Ibrahim, et al.
Pageof 3